PAFDX
Price
$35.51
Change
-$0.04 (-0.11%)
Updated
Jun 5 closing price
Net Assets
16.13B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

PAFDX vs RMEBX

Header iconPAFDX vs RMEBX Comparison
Open Charts PAFDX vs RMEBXBanner chart's image
T. Rowe Price Equity Income Advisor
Price$35.51
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets16.13B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
PAFDX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAFDX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAFDX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. PAFDX (16.1B). PAFDX pays higher dividends than RMEBX: PAFDX (1.56) vs RMEBX (1.16). PAFDX was incepted earlier than RMEBX: PAFDX (25 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than PAFDX (0.98). RMEBX is a more actively managed with annual turnover of: 31.00 vs. PAFDX (21.40). RMEBX has a lower initial minimum investment than PAFDX: RMEBX (250) vs PAFDX (2500). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. PAFDX (-0.57). RMEBX return over 5 years is better than : 49.85 vs. PAFDX (36.45).
PAFDXRMEBXPAFDX / RMEBX
Total Expense Ratio0.981.0792%
Annual Report Gross Expense Ratio0.981.0792%
Fund Existence25 years11 years-
Gain YTD3.3175.34962%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets16.1B105B15%
Annual Yield % from dividends1.561.16135%
Returns for 1 year-0.578.30-7%
Returns for 3 years5.8517.9633%
Returns for 5 years36.4549.8573%
Returns for 10 years24.5768.2136%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA